Combined detection of TBil, CD38, and IL-22 levels demonstrated high sensitivity and specificity for predicting cirrhosis development in AIH patients, highlighting their potential as reliable biomarkers for early identification and risk assessment. Here, CD38 is linked to Cirrhosis.